Eli Lilly and Company

Pharmaceuticals
LLY
$ 369 (1.5)%
Share price
$ 351 bn
Market Cap
$ 369 bn
Enterprise Value

Carbon footprint

1.7 Ton
GHG emissions per $ 1 mln investment
0.05x the weighted average for S&P 500
FY2021
How is this calculated?

Primary Climate Goal

-11%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Stronger than the -6.6% weighted average for S&P 500
FY2022
How is this calculated?

Eli Lilly and Company aims to achieve net zero for Scope 1 + 2 by 2030


This target has not been verified as science based according to SBTi
Eli Lilly and Company's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Eli Lilly and Company's GHG emissions (market-based) (Kt of CO2e)
Eli Lilly and Company's Carbon intensity (Tons per 1 USDm)

Eli Lilly and Company's carbon footprint

Company environmental metrics

Show more...